Wells Fargo & Company Legend Biotech Corp Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Legend Biotech Corp stock. As of the latest transaction made, Wells Fargo & Company holds 12,041 shares of LEGN stock, worth $581,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,041
Previous 15,051
20.0%
Holding current value
$581,459
Previous $844,000
36.85%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$555 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$363 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$320 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$276 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$230 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.08B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...